Prestige Consumer Healthcare Inc. (PBH) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
660 WHITE PLAINS RD. TARRYTOWN, NY 10591 |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
| 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | 12/31/2021 Q3 | 9/30/2021 Q2 | 6/30/2021 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 86 | 42 | 36 | 27 | 21 | 43 | 164 | ||
| Cash and cash equivalents | 86 | 42 | 36 | 27 | 21 | 43 | 164 | ||
| Receivables | 157 | 146 | 145 | 139 | 134 | 147 | 130 | ||
| Inventory, net of allowances, customer advances and progress billings | 159 | 141 | 134 | 120 | 106 | 108 | 106 | ||
| Inventory | 159 | 141 | 134 | 120 | 106 | 108 | 106 | ||
| Other undisclosed current assets | 7 | 8 | 10 | 6 | 14 | 8 | 9 | ||
| Total current assets: | 409 | 337 | 325 | 293 | 275 | 305 | 409 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 5 | 6 | 6 | 7 | 7 | 8 | 8 | ||
| Operating lease, right-of-use asset | 16 | 17 | 19 | 20 | 22 | 22 | 22 | ||
| Property, plant and equipment | 70 | 70 | 70 | 71 | 70 | 70 | 70 | ||
| Intangible assets, net (including goodwill) | 3,247 | 3,247 | 3,259 | 3,276 | 3,283 | 3,269 | 3,048 | ||
| Goodwill | 577 | 576 | 577 | 579 | 579 | 579 | 578 | ||
| Intangible assets, net (excluding goodwill) | 2,670 | 2,671 | 2,683 | 2,697 | 2,704 | 2,690 | 2,470 | ||
| Other noncurrent assets | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||
| Total noncurrent assets: | 3,341 | 3,342 | 3,358 | 3,377 | 3,384 | 3,371 | 3,151 | ||
| TOTAL ASSETS: | 3,750 | 3,679 | 3,682 | 3,671 | 3,659 | 3,676 | 3,559 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 145 | 174 | 177 | 131 | 123 | 129 | 111 | ||
| Interest and dividends payable | ✕ | 16 | 15 | 4 | 15 | 18 | 17 | ||
| Taxes payable | ✕ | 12 | 14 | 3 | 0 | 2 | 8 | ||
| Employee-related liabilities | ✕ | 7 | 5 | 20 | 15 | 12 | 7 | ||
| Accounts payable | 64 | 56 | 58 | 56 | 40 | 38 | 31 | ||
| Accrued liabilities | 81 | 83 | 85 | 48 | 52 | 61 | 48 | ||
| Debt | 3 | 3 | 3 | 3 | 3 | 9 | 3 | ||
| Other undisclosed current liabilities | 12 | (25) | (25) | 10 | 10 | 11 | 11 | ||
| Total current liabilities: | 160 | 152 | 155 | 143 | 135 | 149 | 125 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,442 | 1,471 | 1,508 | 1,497 | 1,572 | 1,637 | 1,570 | ||
| Long-term debt, excluding current maturities | 1,440 | 1,455 | 1,490 | 1,477 | 1,550 | 1,614 | 1,545 | ||
| Finance lease, liability | 2 | 3 | 4 | 5 | 5 | 5 | 6 | ||
| Liabilities, other than long-term debt | 476 | 452 | 451 | 452 | 453 | 449 | 448 | ||
| Deferred income tax liabilities | 456 | 443 | 443 | 445 | 445 | 440 | 439 | ||
| Other liabilities | 9 | 9 | 9 | 7 | 8 | 8 | 9 | ||
| Operating lease, liability | 12 | 13 | 14 | 16 | 18 | 18 | 18 | ||
| Other undisclosed noncurrent liabilities | (16) | (17) | (18) | (20) | (21) | ||||
| Total noncurrent liabilities: | 1,903 | 1,906 | 1,942 | 1,950 | 2,006 | 2,065 | 2,018 | ||
| Total liabilities: | 2,063 | 2,059 | 2,097 | 2,093 | 2,141 | 2,214 | 2,143 | ||
| Equity | |||||||||
| Equity, attributable to parent | 1,687 | 1,620 | 1,585 | 1,578 | 1,518 | 1,462 | 1,416 | ||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Treasury stock, value | (189) | (189) | (177) | (134) | (134) | (134) | (134) | ||
| Additional paid in capital | 533 | 524 | 521 | 516 | 513 | 507 | 504 | ||
| Accumulated other comprehensive loss | (29) | (36) | (29) | (19) | (23) | (24) | (21) | ||
| Retained earnings | 1,372 | 1,320 | 1,269 | 1,214 | 1,162 | 1,112 | 1,067 | ||
| Total equity: | 1,687 | 1,620 | 1,585 | 1,578 | 1,518 | 1,462 | 1,416 | ||
| TOTAL LIABILITIES AND EQUITY: | 3,750 | 3,679 | 3,682 | 3,671 | 3,659 | 3,676 | 3,559 | ||
Income Statement (P&L) ($ in millions) Annual | Quarterly
| 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | 12/31/2021 Q3 | 9/30/2021 Q2 | 6/30/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 276 | 289 | 277 | 381 | 274 | 276 | 269 | |
| Cost of revenue | (125) | (128) | (117) | (171) | (119) | (119) | (110) | |
| Gross profit: | 150 | 161 | 160 | 210 | 155 | 158 | 159 | |
| Operating expenses | (63) | (77) | (73) | (107) | (72) | (79) | (68) | |
| Operating income: | 87 | 84 | 87 | 103 | 83 | 79 | 91 | |
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (1) | (1) | (1) | (2) | (0) | (0) | 0 | |
| Interest and debt expense | (0) | (0) | (0) | (66) | (0) | (2) | (0) | |
| Income from continuing operations before income taxes: | 86 | 84 | 86 | 36 | 82 | 76 | 91 | |
| Income tax expense | (16) | (16) | (16) | (23) | (15) | (14) | (19) | |
| Income from continuing operations: | 70 | 68 | 71 | 13 | 67 | 62 | 73 | |
| Income before gain (loss) on sale of properties: | ✕ | 68 | 71 | 13 | 67 | 62 | 73 | |
| Net income: | 70 | 68 | 71 | 13 | 67 | 62 | 73 | |
| Other undisclosed net income (loss) attributable to parent | (18) | (17) | (15) | 63 | (17) | (16) | (15) | |
| Net income available to common stockholders, diluted: | 52 | 51 | 55 | 76 | 50 | 45 | 58 | |
Comprehensive Income ($ in millions)Annual | Quarterly
| 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | 12/31/2021 Q3 | 9/30/2021 Q2 | 6/30/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 70 | 68 | 71 | 13 | 67 | 62 | 73 | |
| Other comprehensive loss | (0) | (0) | (0) | |||||
| Other undisclosed comprehensive income | 0 | |||||||
| Comprehensive income: | 69 | 68 | 70 | 13 | 67 | 62 | 73 | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (11) | (24) | (25) | 37 | (16) | (20) | (16) | |
| Comprehensive income, net of tax, attributable to parent: | 59 | 44 | 45 | 50 | 51 | 42 | 57 | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.